Drug Type Radiopharmaceuticals and diagnostic agent |
Synonyms- |
Target |
Action inhibitors |
Mechanism PDGFRα inhibitors(Platelet-derived growth factor receptor alpha inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cardiovascular Diseases | Discovery | - | 11 May 2023 | |
| Cardiovascular Diseases | Discovery | - | 11 May 2023 | |
| Gastrointestinal Diseases | Discovery | - | 11 May 2023 | |
| Gastrointestinal Diseases | Discovery | - | 11 May 2023 | |
| Neoplasms | Discovery | - | 11 May 2023 | |
| Neoplasms | Discovery | - | 11 May 2023 | |
| Nervous System Diseases | Discovery | - | 11 May 2023 | |
| Nervous System Diseases | Discovery | - | 11 May 2023 | |
| Other Diseases | Discovery | - | 11 May 2023 | |
| Other Diseases | Discovery | - | 11 May 2023 |





